Silver Book Fact

Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money

Fact image

Pietzsch J, Garner A, Marks W. Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States. Neuromodulation. 2016; 19(7). https://onlinelibrary.wiley.com/doi/abs/10.1111/ner.12474

Reference

Title
Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States
Publication
Neuromodulation
Publication Date
2016
Authors
Pietzsch J, Garner A, Marks W
Volume & Issue
Volume 19, Issue 7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Related Facts

  • Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs…  
  • Research shows that use of donepezil leads to a 4-fold increase in drug costs; however, it significantly lowers overall medical costs, reducing medical treatment and prescription drug costs by $3,891…  
  • Medicines Allow Patients to Remain Independent Longer: New Alzheimer’s medicine delays need for costly home care  
  • Research breakthroughs that slow the onset and progression of Alzheimer’s disease could achieve annual Medicare savings of $51 billion by 2015, $126 billion by 2025, and $444 billion by 2050.  
  • An Alzheimer’s disease treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce Medicaid costs for people with the disease by $14 billion in 2020–from…